ZIRGAN
Total Payments
$62,554
Transactions
27
Doctors
18
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $11,878 | 10 | 6 |
| 2021 | $3,885 | 2 | 2 |
| 2019 | $2,686 | 5 | 4 |
| 2018 | $2,071 | 3 | 1 |
| 2017 | $42,035 | 7 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $44,101 | 5 | 70.5% |
| Consulting Fee | $17,675 | 8 | 28.3% |
| Food and Beverage | $778.31 | 14 | 1.2% |
Payments by Type
Research
$44,101
5 transactions
General
$18,453
22 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Topical Ganciclovir Zirgan for the Treatment of Adenovirus Conjunctivitis | Valeant Pharmaceuticals North America LLC | $40,363 | 0 |
| Efficacy Of Ganciclovir Ophthalmic Gel In the Treatment of Herpes Zoster Keratitis | Bausch Health US, LLC | $2,050 | 0 |
| Efficacy Of Ganciclovir Ophthalmic Gel In the Treatment of Herpes Zoster Keratitis | Valeant Pharmaceuticals North America LLC | $1,560 | 0 |
| Effect of Zirgan on EKC | Bausch Health US, LLC | $128.00 | 0 |
Top Doctors Receiving Payments for ZIRGAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chesterfield, MO | $44,101 | 5 |
| , M.D | Ophthalmology | Woodland Park, NJ | $3,011 | 2 |
| , MD | Ophthalmology | Houston, TX | $3,011 | 2 |
| , M.D | Ophthalmology | Oceanside, NY | $2,440 | 1 |
| , MD | Ophthalmology | Saint Louis, MO | $2,411 | 2 |
| , MD | Ophthalmology | Philadelphia, PA | $2,135 | 1 |
| , MD | Cornea and External Diseases Specialist | Fort Worth, TX | $1,911 | 2 |
| , OD | Optometrist | Scranton, PA | $1,750 | 1 |
| , M.D | Ophthalmology | Largo, FL | $1,450 | 1 |
| , MD | Ophthalmology | Newport Beach, CA | $84.11 | 1 |
| , O.D., F.A.A.O | Corneal and Contact Management | Azusa, CA | $67.19 | 1 |
| , O.D | Optometrist | West Hartford, CT | $48.51 | 1 |
| , M.D | Ophthalmology | San Juan, PR | $22.30 | 1 |
| , M.D | Ophthalmology | Charlottesville, VA | $22.30 | 1 |
| , M.D | Ophthalmology | Bayamon, PR | $22.30 | 1 |
| Raul Perez | Ophthalmology | Rio Piedras, PR | $22.30 | 1 |
| , O.D | Optometrist | San Juan, PR | $22.30 | 1 |
| , O.D | Optometrist | Sparks, NV | $20.87 | 1 |
| , O.D | Optometrist | Philadelphia, PA | $2.13 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $62,554
- Total Doctors 18
- Transactions 27
About ZIRGAN
ZIRGAN is a drug associated with $62,554 in payments to 18 healthcare providers, recorded across 27 transactions in the CMS Open Payments database. The primary manufacturer is Valeant Pharmaceuticals North America LLC.
Payment data is available from 2017 to 2022. In 2022, $11,878 was paid across 10 transactions to 6 doctors.
The most common payment nature for ZIRGAN is "Unspecified" ($44,101, 70.5% of total).
ZIRGAN is associated with 4 research studies, including "Topical Ganciclovir Zirgan for the Treatment of Adenovirus Conjunctivitis" ($40,363).